Skip to main content
PMC home page
Gut logoLink to Gut
. 2000 Jan;46(1):1–4. doi: 10.1136/gut.46.1.1

Hepatopulmonary syndromes

M KROWKA 1
PMCID: PMC1727766  PMID: 10601042

Full Text

The Full Text of this article is available as a PDF (69.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams G. A., Nanda N. C., Dubovsky E. V., Krowka M. J., Fallon M. B. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology. 1998 Feb;114(2):305–310. doi: 10.1016/s0016-5085(98)70481-0. [DOI] [PubMed] [Google Scholar]
  2. Agustí A. G., Cardús J., Roca J., Grau J. M., Xaubet A., Rodriguez-Roisin R. Ventilation-perfusion mismatch in patients with pleural effusion: effects of thoracentesis. Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1205–1209. doi: 10.1164/ajrccm.156.4.9612113. [DOI] [PubMed] [Google Scholar]
  3. Castro M., Krowka M. J., Schroeder D. R., Beck K. C., Plevak D. J., Rettke S. R., Cortese D. A., Wiesner R. H. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc. 1996 Jun;71(6):543–551. doi: 10.4065/71.6.543. [DOI] [PubMed] [Google Scholar]
  4. Clément B., Musso O., Liétard J., Théret N. Homeostatic control of angiogenesis: A newly identified function of the liver? Hepatology. 1999 Mar;29(3):621–623. doi: 10.1002/hep.510290341. [DOI] [PubMed] [Google Scholar]
  5. Duncan B. W., Kneebone J. M., Chi E. Y., Hraska V., Isik F. F., Rosenthal G. L., Jones T. K., Starnes S. L., Lupinetti F. M. A detailed histologic analysis of pulmonary arteriovenous malformations in children with cyanotic congenital heart disease. J Thorac Cardiovasc Surg. 1999 May;117(5):931–938. doi: 10.1016/S0022-5223(99)70374-0. [DOI] [PubMed] [Google Scholar]
  6. Edwards B. S., Weir E. K., Edwards W. D., Ludwig J., Dykoski R. K., Edwards J. E. Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol. 1987 Dec;10(6):1233–1238. doi: 10.1016/s0735-1097(87)80123-7. [DOI] [PubMed] [Google Scholar]
  7. Egawa H., Kasahara M., Inomata Y., Uemoto S., Asonuma K., Fujita S., Kiuchi T., Hayashi M., Yonemura T., Yoshibayashi M. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation. 1999 Mar 15;67(5):712–717. doi: 10.1097/00007890-199903150-00012. [DOI] [PubMed] [Google Scholar]
  8. Fallon M. B., Abrams G. A., Luo B., Hou Z., Dai J., Ku D. D. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology. 1997 Aug;113(2):606–614. doi: 10.1053/gast.1997.v113.pm9247483. [DOI] [PubMed] [Google Scholar]
  9. Findlay J. Y., Plevak D. J., Krowka M. J., Sack E. M., Porayko M. K. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. Liver Transpl Surg. 1999 Sep;5(5):362–365. doi: 10.1002/lt.500050517. [DOI] [PubMed] [Google Scholar]
  10. Gordon F. D., Anastopoulos H. T., Crenshaw W., Gilchrist B., McEniff N., Falchuk K. R., LoCicero J., 3rd, Lewis W. D., Jenkins R. L., Trey C. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology. 1997 Jun;25(6):1366–1369. doi: 10.1002/hep.510250611. [DOI] [PubMed] [Google Scholar]
  11. HOFFBAUER F. W., RYDELL R. Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis. Am J Med. 1956 Sep;21(3):450–460. doi: 10.1016/0002-9343(56)90043-2. [DOI] [PubMed] [Google Scholar]
  12. Hervé P., Lebrec D., Brenot F., Simonneau G., Humbert M., Sitbon O., Duroux P. Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998 May;11(5):1153–1166. doi: 10.1183/09031936.98.11051153. [DOI] [PubMed] [Google Scholar]
  13. Jeffries M. A., Kazanjian S., Wilson M., Punch J., Fontana R. J. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transpl Surg. 1998 Sep;4(5):416–423. doi: 10.1002/lt.500040506. [DOI] [PubMed] [Google Scholar]
  14. Krowka M. J., Frantz R. P., McGoon M. D., Severson C., Plevak D. J., Wiesner R. H. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology. 1999 Sep;30(3):641–648. doi: 10.1002/hep.510300307. [DOI] [PubMed] [Google Scholar]
  15. Krowka M. J. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology. 1997 May;25(5):1282–1284. doi: 10.1002/hep.510250540. [DOI] [PubMed] [Google Scholar]
  16. Krowka M. J., Porayko M. K., Plevak D. J., Pappas S. C., Steers J. L., Krom R. A., Wiesner R. H. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc. 1997 Jan;72(1):44–53. doi: 10.4065/72.1.44. [DOI] [PubMed] [Google Scholar]
  17. Kuo P. C., Johnson L. B., Plotkin J. S., Howell C. D., Bartlett S. T., Rubin L. J. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation. 1997 Feb 27;63(4):604–606. doi: 10.1097/00007890-199702270-00020. [DOI] [PubMed] [Google Scholar]
  18. Kuo P. C., Plotkin J. S., Johnson L. B., Howell C. D., Laurin J. M., Bartlett S. T., Rubin L. J. Distinctive clinical features of portopulmonary hypertension. Chest. 1997 Oct;112(4):980–986. doi: 10.1378/chest.112.4.980. [DOI] [PubMed] [Google Scholar]
  19. Lazaridis K. N., Frank J. W., Krowka M. J., Kamath P. S. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med. 1999 Sep;107(3):262–267. doi: 10.1016/s0002-9343(99)00217-x. [DOI] [PubMed] [Google Scholar]
  20. Mahadeva R., Lomas D. A. Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax. 1998 Jun;53(6):501–505. doi: 10.1136/thx.53.6.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Martinez G., Barberà J. A., Navasa M., Roca J., Visa J., Rodriguez-Roisin R. Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol. 1999 May;30(5):882–889. doi: 10.1016/s0168-8278(99)80143-3. [DOI] [PubMed] [Google Scholar]
  22. Plotkin J. S., Kuo P. C., Rubin L. J., Gaine S., Howell C. D., Laurin J., Njoku M. J., Lim J. W., Johnson L. B. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation. 1998 Feb 27;65(4):457–459. doi: 10.1097/00007890-199802270-00001. [DOI] [PubMed] [Google Scholar]
  23. Ramsay M. A., Simpson B. R., Nguyen A. T., Ramsay K. J., East C., Klintmalm G. B. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg. 1997 Sep;3(5):494–500. doi: 10.1002/lt.500030503. [DOI] [PubMed] [Google Scholar]
  24. Rich S., Dantzker D. R., Ayres S. M., Bergofsky E. H., Brundage B. H., Detre K. M., Fishman A. P., Goldring R. M., Groves B. M., Koerner S. K. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987 Aug;107(2):216–223. doi: 10.7326/0003-4819-107-2-216. [DOI] [PubMed] [Google Scholar]
  25. Robalino B. D., Moodie D. S. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol. 1991 Feb;17(2):492–498. doi: 10.1016/s0735-1097(10)80121-4. [DOI] [PubMed] [Google Scholar]
  26. Srivastava D., Preminger T., Lock J. E., Mandell V., Keane J. F., Mayer J. E., Jr, Kozakewich H., Spevak P. J. Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation. 1995 Sep 1;92(5):1217–1222. doi: 10.1161/01.cir.92.5.1217. [DOI] [PubMed] [Google Scholar]
  27. Tuder R. M., Cool C. D., Geraci M. W., Wang J., Abman S. H., Wright L., Badesch D., Voelkel N. F. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med. 1999 Jun;159(6):1925–1932. doi: 10.1164/ajrccm.159.6.9804054. [DOI] [PubMed] [Google Scholar]
  28. Wencker M., Banik N., Buhl R., Seidel R., Konietzko N. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. Eur Respir J. 1998 Feb;11(2):428–433. doi: 10.1183/09031936.98.11020428. [DOI] [PubMed] [Google Scholar]
  29. Whyte M. K., Hughes J. M., Peters A. M., Ussov W., Patel S., Burroughs A. K. Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome. J Hepatol. 1998 Jul;29(1):85–93. doi: 10.1016/s0168-8278(98)80182-7. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES